| Place of Origin: | China |
|---|---|
| Brand Name: | HNB |
| Certification: | ISO |
| Model Number: | BENFOTIAMINE |
| Minimum Order Quantity: | 1KG |
| Price: | Negotiable |
| Packaging Details: | Aluminum foil bag |
| Delivery Time: | Usually3-5days |
| Payment Terms: | L/C, D/A, D/P, T/T, , MoneyGram，Alibaba Assurance Order |
| Supply Ability: | 5000kg/Month |
| CAS: | 22457-89-2 | Mf: | C19H23N4O6PS |
|---|---|---|---|
| MW: | 466.448 | Specification: | 99% |
| Einecs No.: | / | Appearance: | White Powder |
| Sample: | Available | ||
| High Light: | 22457-89-2 Amino Acid Powder,Amino Acid Powder Benfotiamine,22457-89-2 benfotiamine bulk powder |
||
22457-89-2 SUPPLEMENT INGREDIENTS BENFOTIAMINE
|
Product name |
BENFOTIAMINE |
|
Appearance |
White Powder |
|
CAS |
22457-89-2 |
|
MF |
C19H23N4O6PS |
|
Purity |
99% |
|
Storage |
Keep in cool dry place. |
The Introductction of BENFOTIAMINE
Benfotiamine is a fat-soluble vitamin B1 derivative. In addition to its physical and chemical properties and water-soluble vitamin B1, the difference in structure lies in the fact that it has an open thiazole ring, which forms a physiologically active compound through ring closure in vivo. Vitamin B1.
The Function of BENFOTIAMINE
Benfotiamine is a fat-soluble derivative of vitamin B1, which improves the shortcomings of low bioavailability of water-soluble vitamin B1 and increases the concentration of thiamine in blood and tissues, thereby improving the efficacy.
Benfotiamine has been widely marketed in the United States, Japan, Europe and other parts of the world. Its marketed dosage forms include tablets, granules and other dosage forms. The indications are:
(1) For the prevention and treatment of vitamin B1 deficiency;
(2) It is used for supplementation when the demand for vitamin B1 increases and the intake from food is insufficient (fatigue, hyperthyroidism, pregnancy, lactation, strenuous physical labor, etc.);
(3) For the treatment of non-alcoholic Wernicke encephalopathy;
(4) For the treatment of beriberi;
(5) For the treatment of the following diseases, which are presumed to be related to vitamin B1 deficiency and metabolic disorders, such as: neuralgia; muscle pain, arthralgia; peripheral neuritis, peripheral nerve paralysis; obstacle.
The COA of BENFOTIAMINE
HNB Biotech company details
